For research teamsHelp me find a study
Back to all studies
CompletedNCT02203838

RBP-7000 for schizophrenia

This study is completed in the United States. It is testing RBP-7000 for schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether RBP 7000 may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive RBP 7000, attend study visits with the research team. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJune 2014
Recruitment status
Completed
Enrollment listed in the registry
500
Sponsor
Indivior Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT02203838
Official title
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02203838. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 48 sites
  • Woodland International Research Group, Inc.
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Woodland Research Northwest, LLC
    Springdale, Arkansas
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development
    Cerritos, California
    Site status: Not listed — confirm with the team
  • Synergy EPIC
    Escondido, California
    Site status: Not listed — confirm with the team
  • Behavioral Research Specialists
    Glendale, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network, LLC
    Long Beach, California
    Site status: Not listed — confirm with the team
  • Apostle Clinical Trials
    Long Beach, California
    Site status: Not listed — confirm with the team
  • Pacific Research Partners
    Oakland, California
    Site status: Not listed — confirm with the team
  • Excell Research
    Oceanside, California
    Site status: Not listed — confirm with the team
  • CNRI-Los Angeles
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • CNRI-San Diego
    San Diego, California
    Site status: Not listed — confirm with the team
  • Research Center for Clinical Studies
    Norwalk, Connecticut
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development-Washington DC
    Washington D.C., District of Columbia
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center
    Bradenton, Florida
    Site status: Not listed — confirm with the team
  • Innovative Clinical Research
    Fort Lauderdale, Florida
    Site status: Not listed — confirm with the team
  • Behavioral Clinical Reserach
    Hollywood, Florida
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • Premier Clinical Resarch Institute
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Radiant Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • iResearch Atlanta
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Uptown Research Institute
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • Behavioral Health Hospital
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Baber Research Group
    Naperville, Illinois
    Site status: Not listed — confirm with the team
  • Via Christi Research
    Wichita, Kansas
    Site status: Not listed — confirm with the team
  • Lake Charles Clinical Trials
    Lake Charles, Louisiana
    Site status: Not listed — confirm with the team
  • Centerpointe Hospital
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • St. Louis Clinical Trials
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Altea Research Institute
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • CRI Lifetree - Marlton Unit
    Marlton, New Jersey
    Site status: Not listed — confirm with the team
  • Behavioral Medical Research of Brooklyn
    Brooklyn, New York
    Site status: Not listed — confirm with the team
  • Neurobehavioral Research
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development-Queens
    Jamaica, New York
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • New Hope Clinical Research
    Charlotte, North Carolina
    Site status: Not listed — confirm with the team
  • Clinical Trials of America
    Hickory, North Carolina
    Site status: Not listed — confirm with the team
  • Insight Clinical Trials LLC
    Shaker Heights, Ohio
    Site status: Not listed — confirm with the team
  • Oklahoma Clinical Research Center
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Cutting Edge Research Group
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Keystone Clinical Studies
    Norristown, Pennsylvania
    Site status: Not listed — confirm with the team
  • CRI Lifetree - Philadelphia Unit
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Berks Center for ClinicalResearch
    Reading, Pennsylvania
    Site status: Not listed — confirm with the team
  • Research Strategies of Memphis
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • FutureSearch Clinical Trials
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Community Clinical Research, Inc.
    Austin, Texas
    Site status: Not listed — confirm with the team
  • FutureSearch Clinical Trials, L.P.
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Bayou City Research
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Alliance Research Group
    Richmond, Virginia
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving RBP-7000. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Indivior Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.